I am recognized for my work at the interface of cellular reprogramming and immunology and for fostering development of reprogramming-based immunotherapies. Cellular reprogramming has emerged with stem and developmental biology and has been widely explored in regenerative medicine. Our approach to apply immune reprogramming as a therapeutic option in oncology was transformative. The group has pioneered the induction of immune responses with cell fate reprogramming.
